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Background. Depression is a substantial contributor to the global burden of disease and affects people in all communities across the
globe. Depression is the most common psychiatric problem associated with HIV/AIDS and half of all PLWHIV with depression
go underdiagnosed and untreated. Psychiatric complications of HIVAIDS delay mental health services in less affluent countries.
However, there is lack of studywith regard to the pooled estimation prevalence of depression inPLWHIV inEthiopia.Objectives.The
aimof this systematic review andmeta-analysis is to summarize themost current available evidence from2010 toMarch 2017 among
adult PLWHIV in Ethiopia. Methods. The team explored multiple databases searching methods including MEDLINE/PubMed,
PsycINFO, Google Advance Scholar, and Google Scholar to find studies published with the data on the prevalence of depression
among PLWHIV. We searched 150 research articles; of these 143 articles were excluded. Subsequently, thirteen articles were used
for synthesis prevalence and four studies were included in the synthesis effect of sex on depression among PLWHIV. Results. The
total of pooled estimated prevalence of depression in PLWHIV was 36.65. Estimated prevalence of depression in three studies by
using CES-D was 31.19% and in six studies by using PHQ-9 was 37.91%. The remaining four studies used a single tool: Kessler-6
Scale (15.5%), HADS (41.2%), HDSQ (43.9%), and BDI (55.8%). Factors such as age, marital status, living alone, poor medication
adherence, poor social support, clinical stages II and III of HIV, stigma, income, and occupation were significantly associated with
depression.Conclusions and Recommendation.The pooled estimate prevalence of depression among PLWHIVwas higher than that
in the general population. It is better to offer special attention to these populations.
1. Introduction
Depression is the most common psychiatric problem associ-
ated with HIV disease. The large meta-analysis of 10 studies
found that people living with HIV had twice the risk for
depression than those who were at risk for HIV but were not
actually infected [1]. According to the Joint United Nations
Programme on HIV/AIDS (UNAIDS), as of December 1999,
globally, more than 33 million people were estimated to
be living with HIV/AIDS; among these, 95% were living
in the developing world [2]. Depression rates for HIV-
positive people are about 60%; but half of all PLWHIV with
depression go underdiagnosed and untreated [3]. Depression
is a substantial contributor to the global burden of disease
and affects people in all communities across the globe. Nowa-
days, depression is estimated to affect 350 million people.
The World Mental Health Survey conducted in seventeen
countries found that about 1 in 20 people reported having
an episode of depression in the preceding year [4]. Many
people living with HIV have depression [5, 6]. About 90% of
people who die by suicide have at least one psychiatric diag-
nosis; of these, depressive disorders are the most commonly
associated with suicidal behavior [7]. Undetected mental
health problems such as depression, personality disorders,
cognitive disorders, and cooccurring conditions such as
substance-related disorders can affect drug adherence, clinic
attendance, and quality of life and can influence the outcome
of disease and high-risk behaviors that increase risk of HIV
transmission [8, 9]. Globally, by 2030, depression will be
the leading cause of disease burden. In low- and middle-
income countries, about 76% and 85% of people with severe
mental disorders do not get treatment for their mental
health problem [10]. The prevalence of mental problems in
HIV-infected individuals is significantly higher than that
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Figure 1: Flow chart showing how the research articles were searched (2017) [24].
in the general population [8]. Psychiatric complications of
HIV/AIDS signify a significant additional burden for mental
health services and professionals in less affluent countries
with highHIVprevalence rates [6]. In India, the prevalence of
depression among the HIV/AIDS patients was 40% [11]. The
pooled prevalence of depression in PLWHIV in sub-Saharan
Africa was 9 to 32% [12].The prevalence of depression among
the HIV/AIDS patients in Nigeria was 56.7% [13], in Uganda
it was 47% [14], and in South Africa it was 37.6% [15]; and in
Uganda, depressive symptoms in cognitive function impaired
advanced HIV (53.9%) [16]. In systematic review and meta-
analysis in low-, middle-, and high-income countries, the
prevalence was 12.8 to 78% [17]. In France, it was 28.1% [18];
in three African countries (Kenya, Namibia, and Tanzania),
it was 28% [19]; and in Black Americans it was 58% [20]. In
Ethiopia, the prevalence of HIV is unevenly distributed in
the geographical locations due to varying social, structural,
and economic dynamics. The prevalence of HIV was 1.6%
in Amhara, 1% in Oromia, 1.1% in Somalia, 1.8% in Tigray,
0.9% in SNNP, 5.2% in Addis Ababa, and 2.8% in Harari
[21]. In another study, the prevalence of HIV was 1% in
Harari, 5.8% in Gambela, 0.3% in SNNP, 0.6% in Oromia,
1.1% in Amhara, 0.9% in Afar, and 1.3% in Tigray (1.3%)
[22]. When there is a variation in HIV prevalence, there
is also a variation of depression prevalence. In Africa, the
systematic review showed that factors that associated with
depression among PLWHIV were receiving poor-quality
health services, being female, and lack of emotional support
from friends and family [23]. In Uganda, age above 50
years and being female were associated factors for depression
[14].
The aim of this systematic review and meta-analysis is
to condense the most current available evidence to March
2017 among adult PLWHIV in Ethiopia: (1) prevalence of
depression (defined based on screening tools) and (2) factors
that affect depression in PLWHIV.
2. Methods
2.1. Eligibility Criteria. The PRISMA guidelines protocol was
used to write the systematic review [24]. The studies were
searched in Google advance search: “depression ([MeSH
Terms]) OR mental illnesses ([MeSH Terms]) AND associ-
ated factors ([MeSH Terms]) OR factors associated ([MeSH
Terms]) AND HIV ([MeSH Terms]) OR PLWHIV AND
Ethiopia ([MeSH Terms])” (Figure 1).The date of publication
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from 2010 to March 2017 and age greater than or equal to 18
years were included. Cross-sectional and longitudinal study
designs were included. A comprehensive literature search
was done by the terms “prevalence and associated factors of
depression among PLWHIV in Ethiopia.” Mental illness and
associated factors among PLWHIV in Ethiopia by Cochrane
review database library and PsycINFO search strategies were
also used. Figures were extracted from published reports and
any lost information was gotten from investigators through
email and phone.
2.1.1. Inclusion and Exclusion Criteria. Literatures not written
in the English language and literatures without tool to screen
depression and author were excluded.
2.1.2. Data Extraction and Synthesis. The assessment of each
of the studies in accordance with the checklist revealed that
almost all of the reports were of acceptable quality; there are
eight points used to screen articles; out of these, this review
document was scored 7.77 out of eight points [25]. Data
were primarily appraised for quality and then extraction was
made by using data extraction method. Data were analyzed
using STATA V.14 statistical software. Due to the possibility
of heterogeneity among the studies, random-effects meta-
analysis models were preferentially reported. We developed
the data extraction form that outfits the specific objective
of the systematic review. It included a date of publication,
the name of an author, setting, study methods, and results.
Meta-analysis package was accustomed reason the pooled
prevalence of depression among PLWHIV supported the tool
distinction. The 1st six studies were assessed with PHQ-9
[26–31] and 3 different studies were used (CES-D) [32–34].
The remainder of studies used HADS [35], HDSQ [36], and
BDI [37] and Kessler 6 scale was used to identify depression
[38].
2.1.3. Search Outcomes. The electronic searching of literature
produced 150 articles. Among 150 research articles, 17 were
excluded due to duplication and our inclusion criteria and
118 articles were excluded because title and abstract did not
fit our inclusion criteria. Finally, two articles were excluded
after reading full texts due to the absence of tool and author.
Thirteen research articles were included to quantify the
pooled estimation of depression among PLWHIV and four
studies were included in effect of sex on depression (meta-
analysis) (Figure 1).
2.1.4. Features of Studies. All studies were conducted in
Ethiopia. Eleven of themwere cross-sectional surveys and the
remaining two were cohort and prospective studies (Table 1).
3. Result
Thirteen studies were included in this study. According to
different literatures in Ethiopia, the prevalence of depression
ranged from 7.3% to 73.3%. The pooled estimated preva-
lence of depression among PLWHIV was 36.65% (95% CI:
25.48–47.82). Six regions were incorporated in this study.
In Hara and Southern Nation and Nationalities of People
(SNNP), a single study of each was conducted. In subgroup
analysis related to region, the prevalence ranged from 15.5%
(SNNP) to 64.6% (Oromia region) (Figure 2).
The subgroup analysis of pooled estimated prevalence of
depression in PLWHIV in Ethiopia according to the tool used
ranged from 15.5% (Kessler) to 55.8% (BDI) (Figure 3).
4. Associated Factors for Depression
The factors that affect depression were different according to
different studies (Table 2).
Is being female a risk factor for depression among
PLWHIV? In four studies, being female had no significant
association with depression when compared to being male
(Figure 4).
5. Discussion
The pooled prevalence of depression symptoms in Ethiopia
from 2010 to March 2017 was 36.65% (95% CI: 25.48, 47.82).
The current systematic review result was almost in line with
the pooled prevalence of depression in sub-Saharan African
countries, 9 to 32% [12].Our findingwas similar to the finding
of countries in Sub-Saharan Africa; this is due to Ethiopia
being one of the countries in the Sub-Saharan Africa. The
Ethiopian pooled prevalence of depressive symptoms was
lower than that in the study done in Nigeria (56.7%) [13].
The difference might be due to the fact that the study done in
Nigeria had a single finding, but in Ethiopia the finding was
pooled. This finding was in line with the researches done in
Uganda (47%) [14], South Africa (37.6%) [15], three African
countries (Kenya, Namibia, and Tanzania) (28%) [19], and
France (28.1%) [18]. The finding was in line with the research
done in India (40%) [11]. However, this finding was lower
than the result of Uganda (53.9%) [16] and Black Americans
(58%) [20]. The difference might be that in Uganda the study
was conducted among advanced HIV stage population and
in Black Americans there are sociodemographic and tool
differences. The prevalence of depression among PLWHIV
in low-, middle-, and high-income countries ranged from
12.8% to 78% [17]. Our finding was also in line with this result
because Ethiopia is one of the low-income countries. Based
on the tool, six studies were screened by using PHQ-9 and the
pooled prevalence was 37.91%, which was similar to studies
that screened patients by using Center for Epidemiological
Studies Depression Scale (CES-D) (31.19%) [32–34]. The
reason might be that when the number of studies increases,
the consistency also increases. One study indicated that the
prevalence of depression in PLWHIV was 43.9% by using
Hamilton’s Depression Scale Questionnaire. By using Beck
Depression Inventory (BDI) [37], HADS [35], and Kessler-
6 Scale [38], the prevalence of depression was 55.8%, 41.2%,
and 15%, respectively. In relation to regions, in Addis Ababa,
three studies were conducted and the pooled prevalence was
22.87% (10.55, 35.19) [34, 35, 38], which was in line with the
study done in Amhara region, 28.42% (11.96, 44.88) [27–
29, 33]. This might be due to equivalent number of studies
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Figure 2: The pooled estimated prevalence of depression by region among PLWHIV in Ethiopia, 2017.
(Addis Abba = 3 studies; Amhara = 4 studies). The finding
of Addis Ababa was lower than that of Oromia (64.6%)
[32, 37] and Tigray region (50.97%) (37.25, 64.69) [30, 36].
The reason might be due to the fact that, in Oromia and
Tigray region, two studies of each were conducted but in
Addis Ababa three studies were incorporated, which means
that when the number of studies increases, the precision
of the study increases. The pooled prevalence of depressive
symptoms in Amhara region was lower than that in the
study done in Oromia and Tigray region.The possible reason
might be that in Amhara four studies were included but
not in the counterparts (Oromia and Tigray) and three
of the Amhara region studies were assessed by PHQ-9
[27–29]. The prevalence of depression in Harar [26] and
SNNP [31] was 45.8% and 15.5%, respectively. However, the
finding of these two regions could not be comparable to
other findings because a single study was conducted in each
region.
Perceived HIV stigma and feeling stigmatized [27, 28, 35]
were predictors for depression.The justificationmight be due
to the fact that those who isolated themselves from others
lead to worsening the depression. Poor social support and
living alone [27, 35] are factors that affect the depressive
patients, which was in line with the systematic review study
in Africa [23]. The reason might be due to the fact that those
who did not share their problems with other people had
stress, whichmeans that when the problemswere shared with
others, stress reduced by half. Poor medication adherence
and last time missed any of medication were risk factors for
depression in PLWHIV in Ethiopia [26, 35]. The possible
reason might be due to worsening of the symptoms. Clinical
stage, stage III of HIV [28, 35], and stage IV of HIV/AIDS
[28] were risk factors for depression. The reason might be
due to the fact that psychiatric complications of HIV/AIDS
signify a significant additional burden for mental health
services [6]. Patients who had low income [26, 28, 36] and
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Figure 3: Forest plot presenting subgroup analysis of pooled estimated prevalence of depression according to the tool used among PLWHIV
in Ethiopia, 2017.
experience of quitting work were significantly affected [27].
The reason might be that unfulfillment of human needs leads
to depression. Being hospitalized in the past one month
[28] was also another factor. The reason might be due to
the fact that readmission indicates the complication of the
problems. Being female was not statistically significant, 1.45
(0.91, 2.31), for depression, which contradicts with the finding
of Uganda [14] and sub-Saharan Africa systematic review
[23]. The possible justification was that in this finding we
considered the pooled random-effect size of the four studies
but in Uganda, which had a single study, and in Sub-Saharan
Africa it was described qualitatively. Therefore, this finding
has implication for clinicians as baseline data to link cases
to psychiatry side, to reduce risks like suicide, to increase
antiretroviral drug adherence, to reduce treatment delay, and
to develop depression screening tool. For policymakers, it
is used as baseline data to plan integrating HIV clinic with
mental health and to prepare the guideline for HIV and
mentally ill patients care.
6. Conclusion and Recommendation
The pooled estimate prevalence of depression among
PLWHIV was higher than that in the general population. It
is better to offer special attention to these populations.
Ethical Approval
Since the review was concerned with the research articles,
there was no need for ethical approval and/or additional
consent from participants.
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Figure 4: Forest plot presenting pooled random-effect size (OR) of females related to males in depressive PLWHIV patients in Ethiopia, 2017.
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